List of bibliographic references indexed by Drug Evaluation, Preclinical
Number of relevant bibliographic references: 13.
| Ident. | Authors (with country if any) | Title |
|---|
| 000166 (2021) |
Giulia Fiscon [Italie] ; Federica Conte [Italie] ; Lorenzo Farina [Italie] ; Paola Paci [Italie] | SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. |
| 000326 (2021) |
C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde] | Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus. |
| 000466 (2021) |
Iram Iqbal Hejazi [Inde] ; Md Amjad Beg [Inde] ; Md Ali Imam [Inde] ; Fareeda Athar [Inde] ; Asimul Islam [Inde] | Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease. |
| 000985 (2020) |
Emanuelle Machado Marinho [Brésil] ; João Batista De Andrade Neto [Brésil] ; Jacilene Silva [Brésil] ; Cecília Rocha Da Silva [Brésil] ; Bruno Coelho Cavalcanti [Brésil] ; Emmanuel Silva Marinho [Brésil] ; Hélio Vitoriano Nobre Júnior [Brésil] | Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease. |
| 000C28 (2020) |
Praveen Kumar Tripathi [Inde] ; Saurabh Upadhyay [Inde] ; Manju Singh [Inde] ; Siva Raghavendhar [Inde] ; Mohit Bhardwaj [Inde] ; Pradeep Sharma [Inde] ; Ashok Kumar Patel [Inde] | Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2. |
| 000F10 (2020) |
Allan Sauvat [France] ; Fabiola Ciccosanti [Italie] ; Francesca Colavita [Italie] ; Martina Di Rienzo [Italie] ; Concetta Castilletti [Italie] ; Maria Rosaria Capobianchi [Italie] ; Oliver Kepp [France] ; Laurence Zitvogel [France, République populaire de Chine] ; Gian Maria Fimia [Italie] ; Mauro Piacentini [Italie] ; Guido Kroemer [France, République populaire de Chine, Suède] | On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. |
| 000F31 (2020) |
Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France] | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| 001155 (2020) |
Kyle Rosenke [États-Unis] ; Michael A. Jarvis [États-Unis, Royaume-Uni] ; Friederike Feldmann ; Benjamin Schwarz [États-Unis] ; Atsushi Okumura [États-Unis] ; Jamie Lovaglio ; Greg Saturday ; Patrick W. Hanley ; Kimberly Meade-White [États-Unis] ; Brandi N. Williamson [États-Unis] ; Frederick Hansen [États-Unis] ; Lizette Perez-Perez [États-Unis] ; Shanna Leventhal [États-Unis] ; Tsing-Lee Tang-Huau [États-Unis] ; Julie Callison [États-Unis] ; Elaine Haddock [États-Unis] ; Kaitlin A. Stromberg [États-Unis] ; Dana Scott ; Graham Sewell [Royaume-Uni] ; Catharine M. Bosio [États-Unis] ; David Hawman [États-Unis] ; Emmie De Wit [États-Unis] ; Heinz Feldmann [États-Unis] | Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models. |
| 001294 (2020) |
Suzanne J F. Kaptein [Belgique] ; Sofie Jacobs [Belgique] ; Lana Langendries [Belgique] ; Laura Seldeslachts [Belgique] ; Sebastiaan Ter Horst [Belgique] ; Laurens Liesenborghs [Belgique] ; Bart Hens [Belgique] ; Valentijn Vergote [Belgique] ; Elisabeth Heylen [Belgique] ; Karine Barthelemy [France] ; Elke Maas [Belgique] ; Carolien De Keyzer [Belgique] ; Lindsey Bervoets [Belgique] ; Jasper Rymenants [Belgique] ; Tina Van Buyten [Belgique] ; Xin Zhang [Belgique] ; Rana Abdelnabi [Belgique] ; Juanita Pang [Royaume-Uni] ; Rachel Williams [Royaume-Uni] ; Hendrik Jan Thibaut [Belgique] ; Kai Dallmeier [Belgique] ; Robbert Boudewijns [Belgique] ; Jens Wouters [Belgique] ; Patrick Augustijns [Belgique] ; Nick Verougstraete [Belgique] ; Christopher Cawthorne [Belgique] ; Judith Breuer [Royaume-Uni] ; Caroline Solas [France] ; Birgit Weynand [Belgique] ; Pieter Annaert [Belgique] ; Isabel Spriet [Belgique] ; Greetje Vande Velde [Belgique] ; Johan Neyts [Belgique, États-Unis] ; Joana Rocha-Pereira [Belgique] ; Leen Delang [Belgique] | Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. |
| 001317 (2020) |
Ulf Norinder [Suède] ; Astrud Tuck [Suède] ; Kalle Norgren [Suède] ; Vesna Munic Kos [Suède] | Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19. |
| 001420 (2020) |
Shuofeng Yuan ; Jasper F W. Chan [Hong Kong] ; Kenn K H. Chik ; Chris C Y. Chan ; Jessica O L. Tsang ; Ronghui Liang ; Jianli Cao ; Kaiming Tang ; Lin-Lei Chen ; Kun Wen [République populaire de Chine] ; Jian-Piao Cai ; Zi-Wei Ye ; Gang Lu [République populaire de Chine] ; Hin Chu ; Dong-Yan Jin ; Kwok-Yung Yuen [Hong Kong] | Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. |
| 001545 (2020) |
Peng Liu [France] ; Liwei Zhao [France] ; Gladys Ferrere [France] ; Carolina Alves-Costa-Silva [France] ; Pierre Ly [France] ; Qi Wu [France] ; Ai-Ling Tian [France] ; Lisa Derosa [France] ; Laurence Zitvogel [France] ; Oliver Kepp [France] ; Guido Kroemer [France, République populaire de Chine, Suède] | Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses. |
| 001617 (2020) |
Robin E. Ferner [Royaume-Uni] ; Jeffrey K. Aronson [Royaume-Uni] | Chloroquine and hydroxychloroquine in covid-19. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Drug Evaluation, Preclinical"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i \
-Sk "Drug Evaluation, Preclinical" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Mesh.i
|clé= Drug Evaluation, Preclinical
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 |  |
